Latest filing published 31 May 2024 for Shockwave Medical, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Douglas Evan Godshall across 4 companies, led by Shockwave Medical, Inc., HeartWare International, Inc. and EyePoint, Inc. The record holds 372 filings, for trades running from 20 August 2007 to 31 May 2024.
Both buying and selling appear: 4 purchases worth €196k, against 254 sales worth €115.5M. Taken together, the sales exceed the purchases by €115.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 31 share grants and 80 option exercises. In 2024 alone, the filings show no purchases and 14 sales.
In size, the median ticket on the buying side is €33k.
The newest entry dates from 31 May 2024: a transaction, in Shockwave Medical, Inc. The last insider purchase was made public on 1 April 2019, 2,762 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations